222 related articles for article (PubMed ID: 22190492)
101. Negative co-operativity in the EGF receptor.
Pike LJ
Biochem Soc Trans; 2012 Feb; 40(1):15-9. PubMed ID: 22260659
[TBL] [Abstract][Full Text] [Related]
102. Conformational stability of the epidermal growth factor (EGF) receptor as influenced by glycosylation, dimerization and EGF hormone binding.
Taylor ES; Pol-Fachin L; Lins RD; Lower SK
Proteins; 2017 Apr; 85(4):561-570. PubMed ID: 28019699
[TBL] [Abstract][Full Text] [Related]
103. Regulation of the catalytic activity of the EGF receptor.
Endres NF; Engel K; Das R; Kovacs E; Kuriyan J
Curr Opin Struct Biol; 2011 Dec; 21(6):777-84. PubMed ID: 21868214
[TBL] [Abstract][Full Text] [Related]
104. Exploring higher-order EGFR oligomerisation and phosphorylation--a combined experimental and theoretical approach.
Kozer N; Barua D; Orchard S; Nice EC; Burgess AW; Hlavacek WS; Clayton AH
Mol Biosyst; 2013 Jul; 9(7):1849-63. PubMed ID: 23629589
[TBL] [Abstract][Full Text] [Related]
105. Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment.
Jura N; Endres NF; Engel K; Deindl S; Das R; Lamers MH; Wemmer DE; Zhang X; Kuriyan J
Cell; 2009 Jun; 137(7):1293-307. PubMed ID: 19563760
[TBL] [Abstract][Full Text] [Related]
106. Computational Analysis of Activation of Dimerized Epidermal Growth Factor Receptor Kinase Using the String Method and Markov State Model.
Inoue M; Ekimoto T; Yamane T; Ikeguchi M
J Chem Inf Model; 2024 May; 64(9):3884-3895. PubMed ID: 38670929
[TBL] [Abstract][Full Text] [Related]
107. EGFR activation monitored by SW-FCCS in live cells.
Ma X; Ahmed S; Wohland T
Front Biosci (Elite Ed); 2011 Jan; 3(1):22-32. PubMed ID: 21196281
[TBL] [Abstract][Full Text] [Related]
108. High-throughput selection of transmembrane sequences that enhance receptor tyrosine kinase activation.
He L; Hoffmann AR; Serrano C; Hristova K; Wimley WC
J Mol Biol; 2011 Sep; 412(1):43-54. PubMed ID: 21767549
[TBL] [Abstract][Full Text] [Related]
109. The architecture of EGFR's basal complexes reveals autoinhibition mechanisms in dimers and oligomers.
Zanetti-Domingues LC; Korovesis D; Needham SR; Tynan CJ; Sagawa S; Roberts SK; Kuzmanic A; Ortiz-Zapater E; Jain P; Roovers RC; Lajevardipour A; van Bergen En Henegouwen PMP; Santis G; Clayton AHA; Clarke DT; Gervasio FL; Shan Y; Shaw DE; Rolfe DJ; Parker PJ; Martin-Fernandez ML
Nat Commun; 2018 Oct; 9(1):4325. PubMed ID: 30337523
[TBL] [Abstract][Full Text] [Related]
110. Emerging Allosteric Mechanism of EGFR Activation in Physiological and Pathological Contexts.
Tsai CJ; Nussinov R
Biophys J; 2019 Jul; 117(1):5-13. PubMed ID: 31202480
[TBL] [Abstract][Full Text] [Related]
111. Molecular modeling of nearly full-length ErbB2 receptor.
Bagossi P; Horváth G; Vereb G; Szöllösi J; Tözsér J
Biophys J; 2005 Feb; 88(2):1354-63. PubMed ID: 15596490
[TBL] [Abstract][Full Text] [Related]
112. Tailoring chimeric ligands for studying and biasing ErbB receptor family interactions.
Krueger AT; Kroll C; Sanchez E; Griffith LG; Imperiali B
Angew Chem Int Ed Engl; 2014 Mar; 53(10):2662-6. PubMed ID: 24481645
[TBL] [Abstract][Full Text] [Related]
113. Recent advances in optical cancer imaging of EGF receptors.
Kramer-Marek G; Longmire MR; Choyke PL; Kobayashi H
Curr Med Chem; 2012; 19(28):4759-66. PubMed ID: 22873662
[TBL] [Abstract][Full Text] [Related]
114. Searching for EGF Fragments Recreating the Outer Sphere of the Growth Factor Involved in Receptor Interactions.
Czerczak-Kwiatkowska K; Kaminska M; Fraczyk J; Majsterek I; Kolesinska B
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338748
[TBL] [Abstract][Full Text] [Related]
115. Catalytic control in the EGF receptor and its connection to general kinase regulatory mechanisms.
Jura N; Zhang X; Endres NF; Seeliger MA; Schindler T; Kuriyan J
Mol Cell; 2011 Apr; 42(1):9-22. PubMed ID: 21474065
[TBL] [Abstract][Full Text] [Related]
116. Quantification of receptor tyrosine kinase transactivation through direct dimerization and surface density measurements in single cells.
Swift JL; Godin AG; Doré K; Freland L; Bouchard N; Nimmo C; Sergeev M; De Koninck Y; Wiseman PW; Beaulieu JM
Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7016-21. PubMed ID: 21482778
[TBL] [Abstract][Full Text] [Related]
117. Investigating extracellular in situ EGFR structure and conformational changes using FRET microscopy.
Roberts SK; Tynan CJ; Winn M; Martin-Fernandez ML
Biochem Soc Trans; 2012 Feb; 40(1):189-94. PubMed ID: 22260688
[TBL] [Abstract][Full Text] [Related]
118. Split-enzyme immunoassay to monitor EGFR-HER2 heterodimerization on cell surfaces.
Kim SJ; Dixon AS; Owen SC
Acta Biomater; 2021 Nov; 135():225-233. PubMed ID: 34496282
[TBL] [Abstract][Full Text] [Related]
119. Luciferase fragment complementation imaging in preclinical cancer studies.
Lake MC; Aboagye EO
Oncoscience; 2014; 1(5):310-25. PubMed ID: 25594026
[TBL] [Abstract][Full Text] [Related]
120. Different epidermal growth factor (EGF) receptor ligands show distinct kinetics and biased or partial agonism for homodimer and heterodimer formation.
Macdonald-Obermann JL; Pike LJ
J Biol Chem; 2014 Sep; 289(38):26178-26188. PubMed ID: 25086039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
